Cell Analysis Market Outlook
Cell analysis assists in the study of genetic and phenotypic properties of cells, which are isolated from tissues in multicellular and unicellular organisms. It also aids in identifying genes and protein epigenomics and understanding factors that indicate cell health, death, and proliferation. At present, it is widely utilized in medical research laboratories to identify minority sub-populations of interests, understand population heterogeneity, and discover unique characteristics of individual cells.
What was the size of the global cell analysis market in 2021?
The global cell analysis market reached a value of US$ 17.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 28.8 Billion by 2027, exhibiting a CAGR of 8.97% during 2022-2027.
What are the key factors driving the global cell analysis market?
Cell analysis is used in academic institutions, hospitals, and biotechnology fields for studying stem cells, immunology, neurology, non-invasive prenatal diagnosis, and in-vitro fertilization. This, in confluence with the increasing prevalence of chronic diseases, represents one of the key factors bolstering the market growth. Apart from this, key players are introducing advanced sensors and microscopes and fast detection kits, which are multifunctional and help detect diseases in real-time. This, along with easy access to healthcare facilities, is anticipated to drive the market.
Who are the key players/companies in the global cell analysis market?
The competitive landscape of the industry has also been examined with some of the key players.
- Agilent Technologies Inc.
- BD Biosciences
- Bio-RAD Laboratories Inc.
- Danaher Corporation
- Illumina Inc.
- Merck KGaA
- Miltenyi Biotec
- Olympus Corporation
- PerkinElmer Inc.
- Promega Corporation
- Sysmex Corporation
- Thermo Fisher Scientific
What is the breakup of the global cell analysis market based on ?
The report has categorized the market based on product, analysis type, techniques and end-user.
Breakup by Product:
- Flow Cytometry Products
- qPCR Products
- Cell Microarrays
- Microscopes
- Spectrophotometers
- Cell Counters
- HCS Systems
- Others
Breakup by Analysis Type:
- Cell Identification
- Cell Viability
- Cell Signaling Pathways/Signal Transduction
- Cell Proliferation
- Cell Counting and Quality Control
- Cell Interaction
- Target Identification and Validation
- Single-Cell Analysis
- Others
Breakup by Techniques:
- Molecular Approaches
- Image-Based Approaches
Breakup by End-User:
- Pharmaceutical and Biotechnology Companies and CROs
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Cell Culture Collection Repositories
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
https://asapmix.com/connected-drug-delivery-devices-market-demand/
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800
